bioRxivMolecular BiologyPreprint
Characterization and Validation of a Novel Group of Type V, Class 2 Nucleases for in vivo Genome Editing
Matthew B. BegemanniD, Benjamin N. Gray, Emma January, Anna Singer, Dylan C. Kesler, Yonghua He, Haijun LiuiD, Hongjie Guo, Alex Jordan, Thomas P. BrutnelliD, Todd C. MockleriD, Mohammed Oufattole
Abstract
CRISPR-based genome editing is an enabling technology with potential to dramatically transform multiple industries. Identification of additional editing tools will be imperative for broad adoption and application of this technology. A novel Type V, Class 2 CRISPR nuclease system was identified from Microgenomates and Smithella bacterial species (CRISPR from Microgenomates and Smithella, Cms1). This system was shown to efficiently generate indel mutations in the major crop plant rice (Oryza sativa). Cms1 are distinct from other Type V nucleases, are smaller than most other CRISPR nucleases, do not require a tracrRNA, and have an AT-rich protospacer-adjacent motif site requirement. A total of four novel Cms1 nucleases across multiple bacterial species were shown to be functional in a eukaryotic system. This is a major expansion of the Type V CRISPR effector protein toolbox and increases the diversity of options available to researchers.
- organism: plant (other)
- assay: CRISPR screen
- research focus: variant calling
- approach: experimental assay
- Citations
- 20
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Double nicking by RNA-directed Cascade-nCas3 for high-efficiency large-scale genome engineering
- μCas, a novel class of miniature type-V Cas12f nucleases with diverse PAM
A. Sharrar, L. Arake de Tacca, … M. Schelle·bioRxiv·Feb 3, 2023
- PAM recognition by miniature CRISPR nucleases triggersprogrammable double-stranded DNA target cleavage
T. Karvelis, G. Bigelyte, … V. Siksnys·bioRxiv·Feb 20, 2020
- Genome editing in mammals using CRISPR type I-D nuclease
Keishi Osakabe, Naoki Wada, … Yuriko Osakabe·Communications BiologyPeer-reviewed·Nov 6, 2020
- CRISPR-Cas12a genome editing at the whole-plant level using two compatible RNA virus vectors
M. Uranga, M. Vazquez-Vilar, … J.-A. Daros·bioRxiv·Apr 19, 2021
- A novel mechanistic framework for precise sequence replacement using reverse transcriptase and diverse CRISPR-Cas systems
Y. Bill Kim, Elizabeth B. Pierce, … Aaron W. Hummel·bioRxiv·Dec 13, 2022